Mark Slack
Germany, Hamburg
VP Academic Partnerships, Evotec SE


As Vice-President Academic Partnerships, Mark is responsible for the creation and execution of academic collaborations within Evotec. With a mix of private investors, Evotec´s drug discovery platform and exciting projects selected from leading academic institutes throughout Europe, Mark develops pre-seed stage ideas through to NewCo creation or assets for licensing. Mark brings over 20 years of experience in the preclinical drug discovery space working in multiple therapeutic areas and technology platforms. Previous roles include VP In Vitro pharmacology where he introduced and helped build up Evotec´s stem cell capabilities and licensed in the CRISPR platform to support both internal R&D and external client target identification work.

Processing. Please wait.